Female astronauts drive personalized space medicine, closing knowledge gaps to benefit space travelers and people on Earth.

Results from the company’s Phase I/II trial showed the injectable therapy to have an effective half-life of 91.4 hours.

Anthony Stein, MD, assessed total marrow and lymphoid irradiation with post-transplant cyclophosphamide in patients with ...

Lu rhPSMA-10.1 showed high tumor radiation with low healthy tissue exposure in a phase 1/2 trial for metastatic ...

Guam Regional Medical City announced the addition of Dr. Kin-Sing Au, a board-certified radiation oncologist with more than 30 years of clinical experience in treating cancer, to its growing ...

Interim results from three trials exploring the use of Alpha DaRT® in treating pancreatic cancer showing high disease control rate, impressive ...

Try light therapy if you're fighting fatigue from the time change or struggling with seasonal depression. Here's how it works ...

"With this clearance, our ground-breaking, image guidance technology, IOPS can be utilized across a larger market opportunity in new and expanded clinical applications," said Gulam Khan, CEO of ...

TNBC, aggressive and lacking key receptors, complicates treatment, impacting prognosis and requiring specialized approaches.

Tubular carcinoma, treatable and slow-growing, has a good prognosis and often needs less aggressive treatment.

The Fukushima Daiichi nuclear power plant’s radiation levels have significantly dropped since the cataclysmic meltdown 14 years ago Tuesday. Workers walk around in many ...